An implantable medical device capable of counting and identifying ventricular rate

The implantable medical device accurately identifies ventricular tachycardia and fibrillation by measuring electrocardiogram signals, addressing the need for precise cardiac event differentiation and enabling timely treatment.

CN111714774BActive Publication Date: 2024-12-03SUZHOU SINGULAR MEDICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201911296548.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2019-12-16
Publication Date
2024-12-03
Estimated Expiration
2039-12-16

AI Technical Summary

Technical Problem

Current implantable medical devices lack the capability to accurately identify and differentiate between ventricular tachycardia and fibrillation, which are critical for timely and effective treatment of cardiac arrhythmias, often leading to delayed interventions that can be life-threatening.

Method used

An implantable medical device that automatically counts and identifies ventricular rate by measuring electrocardiogram signals, utilizing threshold values and counters to distinguish between ventricular tachycardia, rapid ventricular tachycardia, and ventricular fibrillation, and includes a processing circuit to transmit detection results to an external computing device.

Benefits of technology

Enables precise identification of cardiac events, allowing for timely and targeted treatment interventions, reducing the risk of life-threatening situations by distinguishing between ventricular tachycardia, rapid ventricular tachycardia, and ventricular fibrillation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN111714774B_ABST
    Figure CN111714774B_ABST
Patent Text Reader

Abstract

The present invention describes an implantable medical device capable of counting and identifying ventricular rate, and counting and identifying cardiac events according to electrocardiogram signals. The implantable medical device implements the counting and identification of cardiac events by an execution unit through computer software. The implantable medical device includes an implantable cardioverter defibrillator (ICD), an implantable cardiac monitor (ICM), an implantable cardiac pacemaker (Cardiac Pacemaker), a leadless implantable cardiac pacemaker and a subcutaneous implantable cardiac defibrillator (SICD).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to an implantable medical device, which can count and identify cardiac event types or cardiac disease types by monitoring electrocardiogram signals, and is used for clinical monitoring, identification or treatment of cardiac events or arrhythmias. Background Art

[0002] Implantable cardioverter defibrillators (ICDs), implantable cardiac monitors (ICMs), cardiac pacemakers or leadless implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators (SICDs) are important medical devices for the clinical treatment of persistent or fatal ventricular arrhythmias.

[0003] Implantable cardioverter-defibrillator (ICD) is an important therapeutic device for the clinical treatment of persistent or fatal ventricular arrhythmias, with supportive, anti-tachycardia pacing, low-energy cardioversion and high-energy defibrillation functions.

[0004] At present, the sensing of ventricular rate has become an existing technology, which can be sensed by implanting a device equipped with sensing components inside the heart or placing it outside the patient's body for sensing. The signals sensed inside the ventricle include heart sounds, rate, amplitude, frequency, period, etc.

[0005] If the patient is not treated in time when ventricular fibrillation occurs, the patient will miss the best time for treatment, which may even lead to life-threatening situations. ICD can identify the patient's rapid ventricular arrhythmia within a few seconds, and then automatically discharge and defibrillate, which can significantly avoid the incidence of sudden death caused by malignant ventricular arrhythmia, thus avoiding the situation of delayed treatment.

[0006] Heart disease is a general term for all heart diseases, but in clinical practice, the treatment of heart disease needs to be determined based on the severity of the disease and the location of the disease. Different types of heart disease require different treatments.

[0007] In order to accurately identify the type of heart disease a patient suffers from and achieve better treatment results, it is clinically necessary to make a more detailed classification of the types of heart disease. This goal is usually achieved during the identification process of heart disease.

[0008] Currently, a typical method for identifying the type of heart disease is to determine whether there is ventricular tachycardia or ventricular fibrillation through real-time heart rate counting, and to provide treatment based on the judgment results. Summary of the invention

[0009] The present invention provides a method for counting and judging the types of heart diseases inside a living organism by measuring the ventricular rate, and is applicable to medical equipment and clinical fields.

[0010] The present invention discloses an implantable medical device that triggers counting and identifying ventricular rate by measuring a patient's electrocardiogram signal. In some examples, triggering of these measurements can be done automatically (e.g., without a trigger input initiated from an external source, such as based on a request initiated from the patient or by a physician from an external device), and triggering measurement of ventricular rate can occur within certain ranges of values ​​based at least in part on monitoring one or more physiological parameters associated with the patient.

[0011] The present invention provides a system including an implantable medical device (IMD). The IMD system may include: a communication circuit system configured to communicate with an external computing device, a sensing circuit system configured to sense a cardiac signal that changes according to a patient's ventricular rate, and a processing circuit system. The processing circuit system may be configured to: determine a series of continuous heart disease threshold value ranges based on the sensed heart signal; and identify the type of heart disease based on each heart disease threshold value of the different types of heart diseases. The processing circuit system may be further configured to: detect a pause in the patient's heart disease based on the sensed heart signal, and control the communication circuit system to transmit an indication of the detected pause in the heart disease to an external computing device.

[0012] The present invention provides an implantable medical device with a ventricular tachycardia counting function, characterized in that the implantable medical device is configured as follows:

[0013] Step a: updating the real-time heart rate value according to the ECG signal;

[0014] Step b: updating the ventricular tachycardia count value by the ventricular tachycardia counter;

[0015] The step b also includes:

[0016] In step b1, the real-time heart rate value is compared with the ventricular tachycardia threshold value. When the real-time heart rate value is less than the ventricular tachycardia threshold value, the ventricular tachycardia count value is reset to zero and starts counting again.

[0017] Step b2: when the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value and less than the rapid ventricular tachycardia threshold value, the ventricular tachycardia count value is increased by 1;

[0018] Step b3: When the real-time heart rate value is greater than or equal to the fast ventricular tachycardia threshold value, the ventricular tachycardia counter does not count.

[0019] The present invention provides an implantable medical device with a ventricular tachycardia recognition function, characterized in that the implantable medical device is configured as follows:

[0020] Step a: updating the real-time heart rate value according to the ECG signal;

[0021] Step b: updating the ventricular tachycardia count value by the ventricular tachycardia counter;

[0022] The step b also includes:

[0023] In step b1, the real-time heart rate value is compared with the ventricular tachycardia threshold value. When the real-time heart rate value is less than the ventricular tachycardia threshold value, the ventricular tachycardia count value is reset to zero and starts counting again.

[0024] Step b2: when the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value and less than the rapid ventricular tachycardia threshold value, the ventricular tachycardia count value is increased by 1;

[0025] Step b3: When the real-time heart rate value is greater than or equal to the fast ventricular tachycardia threshold value, the ventricular tachycardia counter does not count;

[0026] Step b4: When the ventricular tachycardia count value reaches the first threshold, it is identified as ventricular tachycardia; otherwise, the real-time heart rate value continues to be updated.

[0027] The recognition module can induce a corresponding treatment module.

[0028] In the implantable medical device with ventricular tachycardia recognition function, when the ventricular tachycardia count value is increased by 1 and has not reached the first threshold value, the ventricular tachycardia count value is added to the original ventricular tachycardia count value.

[0029] The present invention provides an implantable medical device with a cardiac event counting function, characterized in that the medical device is configured as follows:

[0030] Step a: updating the real-time heart rate value according to the ECG signal;

[0031] Step B continuously updates the ventricular fibrillation count value according to the real-time heart rate value, and the ventricular fibrillation count value is equal to the number of real-time heart rate values ​​in the shift register that are greater than the rapid ventricular tachycardia threshold value;

[0032] Step B1: when the ventricular fibrillation count value is less than the second threshold value, return to step a to continue updating the real-time heart rate value;

[0033] Step B2: When the ventricular fibrillation count value reaches the second threshold, the combined counter is triggered, and the combined counter updates the combined count value, where the combined count value = ventricular tachycardia count value + ventricular fibrillation count value.

[0034] Step b: updating the ventricular tachycardia count value by the ventricular tachycardia counter;

[0035] The step b also includes:

[0036] In step b1, the real-time heart rate value is compared with the ventricular tachycardia threshold value. When the real-time heart rate value is less than the ventricular tachycardia threshold value, the ventricular tachycardia count value is reset to zero and starts counting again.

[0037] Step b2: when the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value and less than the rapid ventricular tachycardia threshold value, the ventricular tachycardia count value is increased by 1;

[0038] Step b3: When the real-time heart rate value is greater than or equal to the fast ventricular tachycardia threshold value, the ventricular tachycardia counter does not count.

[0039] The calculation method of the ventricular fibrillation count value is:

[0040] Step a: updating the real-time heart rate value according to the ECG signal;

[0041] Step C updates the shift registers x(n-m+1), x(nm), ..., x(n) according to the real-time heart rate value;

[0042] In step D, the ventricular fibrillation count value is equal to the number of real-time heart rate values ​​in the shift register that are greater than the rapid ventricular tachycardia threshold value.

[0043] In the implantable medical device with a cardiac event counting function, the shift register shifts once each time the real-time heart rate value is updated.

[0044] The present invention provides 12. an implantable medical device with a cardiac event recognition function, wherein the implantable medical device is configured as follows:

[0045] Step a: updating the real-time heart rate value according to the ECG signal;

[0046] Step C updates the shift registers x(n-m+1), x(nm), ..., x(n) according to the real-time heart rate value;

[0047] Step B continuously updates the ventricular fibrillation count value according to the real-time heart rate value, and the ventricular fibrillation count value is equal to the number of real-time heart rate values ​​in the shift register that are greater than the rapid ventricular tachycardia threshold value;

[0048] Step B1: when the ventricular fibrillation count value is less than the second threshold value, return to step a to continue updating the real-time heart rate value;

[0049] Step B2: When the ventricular fibrillation count value reaches the second threshold, the combined counter is triggered, and the combined counter updates the combined count value, where the combined count value = ventricular tachycardia count value + ventricular fibrillation count value;

[0050] In step D, when the joint count value reaches the third threshold, the backtracking window is started, and the calculation method of the backtracking window is:

[0051] Step E detects whether there is a real-time heart rate value within the ventricular fibrillation zone in the lookback window. If there is at least one implemented heart rate value within the ventricular fibrillation zone, the cardiac event is identified as ventricular fibrillation. If not, continue to identify whether there is a real-time heart rate value within the rapid ventricular tachycardia zone in the lookback window. If there is at least one implemented heart rate value within the rapid ventricular tachycardia zone, it is identified as rapid ventricular tachycardia, otherwise it is identified as ventricular tachycardia. BRIEF DESCRIPTION OF THE DRAWINGS

[0052] Figure 1 Schematic diagram of the structure of the ICD in the implantable medical device

[0053] Figure 2 Flow chart of the method for counting ventricular tachycardia for implantable medical devices

[0054] Figure 3 Flow chart of the method for identifying ventricular tachycardia in implantable medical devices

[0055] Figure 4 Schematic diagram of the logical structure of the real-time heart rate value sequence in the lookback window

[0056] Figure 5 Schematic diagram of ventricular fibrillation counting process in cardiac event counting method for implantable medical device

[0057] Figure 6 Schematic diagram of ventricular fibrillation recognition process in cardiac event recognition method for implantable medical devices

[0058] Figure 7 Flowchart of a cardiac event counting method for an implantable medical device

[0059] Figure 8 Schematic diagram of a cardiac event recognition method for an implantable medical device DETAILED DESCRIPTION

[0060] The drawings and descriptions provided herein illustrate and describe various examples of the inventive methods, devices, and systems of the present disclosure. However, the methods, devices, and systems of the present disclosure are not limited to the specific examples shown and described herein, and as will be understood by those of ordinary skill in the art, other examples and variations of the methods, devices, and systems of the present disclosure are considered to be within the scope of the present application.

[0061] The counting and identification method of the present invention is applicable to medical devices including implantable cardioverter defibrillator (ICD), implantable cardiac monitor (ICM), implantable cardiac pacemaker (Cardiac Pacemaker), leadless implantable cardiac pacemaker and subcutaneous implantable cardiac defibrillator (SICD). It can automatically identify ventricular tachycardia events. Taking an implantable cardioverter defibrillator (ICD) as an example, a counting method for ventricular rate (abbreviated as ventricular tachycardia) and its corresponding ventricular tachycardia identification method, a cardiac event joint counting method and its corresponding joint identification method are described.

[0062] The medical device is configured to increase the count value of the counter when ventricular tachycardia, ventricular tachyarrhythmia events and ventricular fibrillation events are detected; the implantable medical device counts cardiac events through an execution unit, and the execution unit is configured to subsequently transmit programming instructions from the execution circuit to the implantable medical device. Cardiac events are counted and identified by sensing electrocardiogram signal parameters. The counting method is a computer program method implemented by a programming language, and counting is a part of identification, which is triggered by the corresponding counting results. The present invention divides the counting and identification of cardiac events into three areas of ventricular tachycardia, rapid ventricular tachycardia and ventricular fibrillation according to the size of the real-time heart rate value. The three areas cover all real-time heart rate values, and the real-time heart rate value increases continuously according to the three areas of ventricular tachycardia, rapid ventricular tachycardia and ventricular fibrillation.

[0063] In the present invention, "Y" in all flow charts represents "Yes", meaning "yes", and "N" represents "No", meaning no.

[0064] Figure 1 It is a schematic diagram of the appearance structure of ICD100 and the relative positions of its various components in the heart when it is implanted inside the heart. The ICD includes a main structure and a wire 115. The main structure consists of two parts: a main shell 105 and a connector 107 on the main shell. The interior of the main shell usually contains three parts: a power supply, a capacitor, and a hybrid circuit. The hybrid circuit is usually implemented by encoding the program on a chip. The function of the ICD can be realized in two ways. One is the automatic regulation inside the ICD body, which does not require manual triggering and control and can be realized automatically. The other is to send a communication signal 185 through an external control device 190. The external control device 190 of the ICD is generally a program controller, a patient assistant, or other device that can issue instructions to it or sense its internal signals. The communication method 185 between the ICD and the external control device 190 can be one or more of wired communication, Bluetooth, WIFI, LTE or CDMA and other wireless communication networks. This Figure 1The ICD lead 115 shown is a single lead, and may also be a double lead, a triple lead, or a quad lead during clinical use, and the basic structure of the lead is similar to that of the lead 115. The lead 115 is composed of a coil 118, an electrode 120A, and an electrode 120B. The coil 118 is connected to the ICD body through a connector 107, and the function of the coil is to achieve the purpose of treatment through discharge. Electrode 120A and electrode 120B sense the signal parameters of the cardiac event. Electrode 120B, also called a spiral head, contains a spiral coil inside, which can be suspended from the other side of the lead when in use and fixed to the tissue inside the heart, so that after the ICD is implanted in the human heart, the electrodes on the device can be firmly connected to the myocardium.

[0065] Figure 2 The present invention is a schematic diagram of the ventricular tachycardia counting process of an implantable medical device. First, step 202 updates the real-time heart rate value according to the electrocardiogram signal, and step 204 compares the real-time heart rate value with the ventricular tachycardia threshold value. If the real-time heart rate value is less than the ventricular tachycardia threshold value, the ventricular tachycardia counter is reset to zero and restarts counting, and returns to step 202 to re-update the real-time heart rate value; if the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value, step 206 is performed to compare it with the rapid ventricular tachycardia threshold value. If the real-time heart rate value is less than the rapid ventricular tachycardia threshold value, the ventricular tachycardia count value is increased by 1, and the ventricular tachycardia count value is updated by the ventricular tachycardia counter; if the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value, the ventricular tachycardia count value remains unchanged, that is, the event is not counted, and returns to step 202 to continue updating the real-time heart rate value. In the present invention, the ventricular tachycardia threshold value ranges from 150 to 200 bpm, and the rapid ventricular tachycardia threshold value ranges from 200 to 250 bpm.

[0066] Figure 3The figure is a flow chart of ventricular tachycardia recognition for implantable medical devices. The recognition event is triggered by the corresponding counting result. First, step 302 updates the real-time heart rate value according to the electrocardiogram signal. Then, step 304 compares the real-time heart rate value with the ventricular tachycardia threshold value. If the real-time heart rate value is less than the ventricular tachycardia threshold value, the ventricular tachycardia counter is reset to zero and starts counting again, and returns to step 302 to re-update the real-time heart rate value; if the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value, step 306 is performed to compare it with the rapid ventricular tachycardia threshold value. If the real-time heart rate value is less than the rapid ventricular tachycardia threshold value, the ventricular tachycardia count value is increased by 1, and the update of the ventricular tachycardia count value is completed by the ventricular tachycardia counter; if the real-time heart rate value is greater than or equal to the ventricular tachycardia threshold value, the ventricular tachycardia count value remains unchanged, that is, this event is not counted, and returns to step 302 to continue updating the real-time heart rate value. When the ventricular tachycardia count value is greater than the ventricular tachycardia threshold value and less than the rapid ventricular tachycardia threshold value, this ventricular tachycardia counting event is a valid event, and the ventricular tachycardia counter triggers the counting step. As the real-time heart rate value is continuously updated, when the ventricular tachycardia count value does not reach the first threshold value and satisfies the ventricular tachycardia counting condition, the ventricular tachycardia count value is continuously added and counted. When the ventricular tachycardia count value reaches the first threshold value (see step 310), it is identified as ventricular tachycardia. The first threshold value is 12.

[0067] Figure 5 The present invention is a schematic diagram of the ventricular fibrillation counting process in the cardiac event counting method of an implantable medical device. First, step 502 continuously updates the real-time heart rate value through the electrocardiogram signal, and step 504 updates the shift register x(n-m+1), x(n-m+2), ..., x(n). The real-time heart rate data sequence contained in the shift register during the ventricular fibrillation counting process of the present invention is 24 bits, that is, each time the current real-time heart rate is updated and a total of 24 real-time heart rate sequences are updated in this way. Step 506 represents the counting condition of the ventricular fibrillation count value, that is, the ventricular fibrillation count value is equal to the number of 24-bit real-time heart rate value sequences updated by the shift register that are greater than the ventricular speed threshold value.

[0068] Figure 6 The present invention is a schematic diagram of the ventricular fibrillation identification process in the cardiac event identification method of an implantable medical device. The overall method includes two parts: updating the ventricular fibrillation counter and judging the ventricular fibrillation events in the backtracking window. In the first part, the ventricular fibrillation counter is updated, and the real-time heart rate value higher than the rapid ventricular speed zone is used as the basis for judging the ventricular fibrillation event. First, step 602 updates the real-time heart rate value according to the electrocardiogram signal, step 604 compares the real-time heart rate value with the rapid ventricular speed threshold value, and step 606 determines the ventricular fibrillation event count value according to the comparison result. The ventricular fibrillation count value is the number of real-time heart rate values ​​in the shift register that are greater than the rapid ventricular speed threshold value, and the rapid ventricular speed threshold value is 200-250bpm. If the ventricular fibrillation count value reaches the third threshold value, the judgment of the ventricular fibrillation event in the backtracking window of the second part is started. If the ventricular fibrillation count value does not reach the third threshold value, return to step 602 to continue updating the real-time heart rate value. Figure 6The third threshold is 18, that is, when 18 of the 24 real-time heart rate values ​​in the shift register are in the ventricular fibrillation zone, the ventricular fibrillation count value reaches the threshold 18, and the lookback window is started, and the heart rate value range of the ventricular fibrillation zone is 200-250 bpm. According to step 610, the real-time heart rate value sequence in the lookback window is updated, and step 610 compares all the real-time heart rate values ​​in the lookback window with the heart rate value in the ventricular fibrillation zone. If there is at least one real-time heart rate value in the ventricular fibrillation zone, it is identified as ventricular fibrillation, otherwise, it is identified as rapid ventricular tachycardia.

[0069] Figure 7 The present invention is a flowchart of a cardiac event counting method for an implantable medical device. The present invention includes two parts: determining the ventricular fibrillation condition and starting the joint counter. The first part determines the ventricular fibrillation condition based on the real-time heart rate value. First, step 702 updates the real-time heart rate value based on the electrocardiogram signal. Step 704 continuously updates the ventricular tachycardia counter and the ventricular fibrillation counter based on the real-time heart rate value obtained in step 702. The method for updating the ventricular tachycardia counter to calculate the ventricular tachycardia count value is shown in FIG. Figure 2 , the method for updating the ventricular fibrillation counter to calculate the ventricular fibrillation count value is shown in Figure 5 . Step 706 compares the ventricular fibrillation count value with the second threshold value. When the ventricular fibrillation count value reaches the second threshold value, the second part is entered. The second threshold value of the ventricular fibrillation counter of the present invention is 6. In actual operation, the second threshold value can be slightly modified according to actual needs. Step 708 starts the joint counter. Step 710 calculates the joint count value by updating the joint counter. The joint counter is updated based on the ventricular tachycardia counter and the ventricular fibrillation counter. The joint count value = ventricular tachycardia count value + ventricular fibrillation count value.

[0070] Figure 4 The figure is a schematic diagram of the logical structure of the real-time heart rate value sequence of the backtracking window. The backtracking window refers to several quantity units of the real-time heart rate, that is, the current real-time heart rate traces back a certain number of real-time heart rate values. The number of backtracking windows can be adjusted according to actual needs, and the number units of all backtracking windows described in the present invention are 8. The real-time heart rate value is recorded as x(n), then the backtracking windows are x(n-7), x(n-6), .....x(n-1), x(n). The real-time heart rate in the backtracking window is stored in a shift register, and the shift register shifts once each time the real-time heart rate value is updated. The shift register not only has the function of updating the real-time heart rate value, but also has the function of recording and storing the real-time heart rate value sequence, and can store all real-time heart rate value data sequences in the current backtracking window.

[0071] Figure 8Flow chart of the cardiac event identification method for implantable medical devices. It includes three parts: judging ventricular fibrillation conditions, starting a joint counter, and starting a backtracking window. The first part judges the ventricular fibrillation conditions based on the real-time heart rate value. Step 802 updates the real-time heart rate value based on the electrocardiogram signal. Step 804 continuously updates the ventricular tachycardia counter and the ventricular fibrillation counter based on the real-time heart rate value obtained in 802. Step 806 compares the ventricular fibrillation count value with the second threshold, and enters the second part when the ventricular fibrillation count value reaches the second threshold. Step 808 starts the joint counter, and step 810 compares the joint count value with the third threshold, the joint count value = ventricular tachycardia count value + ventricular fibrillation count value. If the joint count value does not reach the third threshold, return to step 804 to continue updating the ventricular fibrillation counter and the ventricular tachycardia counter; if the joint count value reaches the third threshold, start the backtracking window according to step 812. The joint count threshold T5 described in the present invention takes a value of 21. After starting the backtracking window, according to Figure 4 A sequence of real-time heart rate values ​​in the lookback window is obtained, and step 814 determines whether there is a ventricular fibrillation event in the lookback window, that is, determines whether there is a real-time heart rate value located in the ventricular fibrillation zone in the lookback window. If so, it is identified as ventricular fibrillation; if not, it continues to determine whether there is a rapid ventricular tachycardia event in the lookback window, that is, determines whether there is a real-time heart rate value located in the rapid ventricular tachycardia zone in the lookback window. If so, it is identified as rapid ventricular tachycardia; otherwise, it is identified as ventricular tachycardia.

[0072] The algorithm can be used for implantable medical devices to calculate and identify the ventricular rate inside the heart. There are two ways to implement these two functions: one is to automatically run to complete the measurement of ECG signals and the counting and identification of cardiac events; the other is to manually control the execution to complete the measurement of ECG signals and the counting and identification of cardiac events. The second method is to connect with the patient assistant and transmit the sensed ECG signal data to the patient assistant. By sending the patient assistant to the hospital for identification, the patient does not need to go to the hospital in person, which brings convenience to the patient to a great extent. It can also be connected to a remote device to set and adjust the parameters of the medical device implanted in the body through the remote device.

[0073] The identification results are divided into three areas: ventricular tachycardia, rapid ventricular tachycardia and ventricular fibrillation. The corresponding treatment modules are divided into three modules: ventricular tachycardia treatment module, rapid ventricular tachycardia treatment module and ventricular fibrillation treatment module. The working state (activation / dormancy) of the treatment is determined by the results of the identification phase. After the current treatment module implements the treatment measures, the module will monitor the patient's heart rate after the treatment and prepare for the next treatment. If the module finds that the treatment fails, it will continue to implement the next treatment measure until the patient's heartbeat returns to normal or the number of treatment measures reaches the upper limit.

Claims

1. An implantable medical device with a cardiac event recognition function, the implantable medical device being configured as follows: Step a: updating the real-time heart rate value according to the ECG signal; Step C updates the shift registers x(n-m+1), x(nm), ..., x(n) according to the real-time heart rate value; Step B continuously updates the ventricular fibrillation count value according to the real-time heart rate value, and the ventricular fibrillation count value is equal to the number of real-time heart rate values ​​in the shift register that are greater than the rapid ventricular tachycardia threshold value; Step B1: when the ventricular fibrillation count value is less than the second threshold value, return to step a to continue updating the real-time heart rate value; Step B2: When the ventricular fibrillation count value reaches the second threshold, the combined counter is triggered, and the combined counter updates the combined count value, where the combined count value = ventricular tachycardia count value + ventricular fibrillation count value; In step D, when the joint count value reaches the third threshold, the backtracking window is started, and the calculation method of the backtracking window is: Step E detects whether there is a real-time heart rate value within the ventricular fibrillation zone in the lookback window. If there is at least one implemented heart rate value within the ventricular fibrillation zone, the cardiac event is identified as ventricular fibrillation. If not, continue to identify whether there is a real-time heart rate value within the rapid ventricular tachycardia zone in the lookback window. If there is at least one implemented heart rate value within the rapid ventricular tachycardia zone, it is identified as rapid ventricular tachycardia, otherwise it is identified as ventricular tachycardia.

2. An implantable medical device with a cardiac event recognition function as claimed in claim 1, wherein the unit length of the lookback window is 8.

3. An implantable medical device with a cardiac event recognition function as claimed in claim 2, wherein the value of the third threshold is 21.

4. The implantable medical device with ventricular tachycardia counting function as claimed in claim 1, characterized in that: The method for determining the rapid ventricular tachycardia threshold value is: to determine an integer value between 200-250 bpm.

5. The implantable medical device with ventricular tachycardia recognition function as claimed in claim 1, characterized in that: The results identified in step E trigger corresponding treatment modules.

6. An implantable medical device with cardiac event counting function as claimed in claim 1, characterized in that: Each time the real-time heart rate value is updated, the shift register shifts once.

7. An implantable medical device with a cardiac event counting function as claimed in claim 1, wherein the value of the second threshold is 6.